Výsledky vyhledávání - "Daniela Lebrun-Jezekova"

Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis

Autor: Pascale Mariani, Estelle Botton, Alain Landau, Joëlle Blumberg, D. Mayeur, Robert Herve, Daniela Lebrun-Jezekova, Pascal Maisonobe, Olivier Beatrix, Laure Chauvenet

Publikováno v: Obstetrical & Gynecological Survey. 68:437-438

Purpose To investigate the somatostatin analog lanreotide as symptomatic treatment for inoperable bowel obstruction due to peritoneal carcinomatosis. Patients and Methods In all, 80 patients with peritoneal carcinomatosis, inoperable malignant digest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d970cd70f1149bec9812e93dc7518c
https://doi.org/10.1097/ogx.0b013e318294c9b8

Zobrazit plný text záznamu

Development of a geriatric vulnerability score (GVS) in elderly advanced ovarian cancer (AOC) patients (pts) treated in first line: A prospective GINECO trial

Autor: Emmanuel Sevin, Béatrice Weber, Olivier Tredan, Fabien Tinquaut, Laetitia Stefani, Eric Pujade-Lauraine, Gilles Freyer, Claire Falandry, Daniela Lebrun-Jezekova

Publikováno v: Journal of Clinical Oncology. 30:9079-9079

9079 Background: Two previous prospective GINECO studies in elderly patients have underlined the prognostic value of geriatric covariates (Co) on overall survival (OS) (Freyer G., et al. Ann Oncol. 2005 and Tredan O, et al Ann Oncol 2007). Methods: T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4f8729bacd46ff226b3126ba8e918d83
https://doi.org/10.1200/jco.2012.30.15_suppl.9079

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání